The global actinic keratosis treatment market is projected to grow at a considerable CAGR of 4.7% during the forecast period (2020-2026). Actinic keratosis is a common skin lesion associated with an increased risk of developing squamous cell carcinoma. The prevalence of actinic keratosis is highest in Australia, with an estimated prevalence of 37-55% in Australian adults over the age of 40. The overall rate of prevalence of actinic keratosis in the US is estimated to be approximately 10.2% in females and 26.5% in males. In the UK, the prevalence is 15% in males and 6% in females. 

The rising awareness related to actinic keratosis treatment options, growing exposure to sunlight due to the depleting ozone layer, and increasing incidence and prevalence rate of actinic keratosis are the major factors that are anticipated to drive the growth of the global actinic keratosis treatment market. The geriatric population is more prone to the development of actinic keratosis. Therefore, the increasing geriatric population is fueling the demand for the actinic keratosis treatment market across the globe. The high cost associated with actinic keratosis treatment and the availability of limited treatment options may restrain the growth of the market across the globe.

Segmental Outlook  

The actinic keratosis treatment market is segmented based on type, and end-user. Based on the type, the market is segmented into medication, therapy, and other (combination therapy). Medication to showcase considerable growth based on treatment type. The growing FDA approval for the new drugs to treat actinic keratosis is anticipated to drive the growth of this market segment. Based on medication, the market is segmented into fluorouracil, imiquimod, ingenol mebutate, others. Based on therapy, the market is segmented into photodynamic therapy and LASER surgery. Based on end-user, the market is segmented into hospitals & oncology centers, and dermatology clinics.

Hospitals & Oncology Centers to be considerable segment based on End-User

The ease of availability of patient pool in hospitals & oncology centers owing to the availability of required medications and therapies at a single place is a key factor contributing towards the high share of this market segment. Moreover, the developing healthcare infrastructure in the developing economies across the globe is anticipated to drive the growth of the market growth. 

Global Actinic Keratosis Treatment Market Share by End-User, 2019 (%)

Regional Outlook 

The global actinic keratosis treatment market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America is anticipated to hold a considerable market share during the forecast period. The US is anticipated to hold a major market share in the North American actinic keratosis treatment market. According to the American Academy of Dermatology Association, it is estimated that more than 40 million Americans develop actinic keratoses each year in the US. The high prevalence of actinic keratosis in the country due to the growing geriatric population is anticipated to be a key factor contributing to the high share of the market in the US. The presence of huge funding for R&D of the treatment drugs and therapies and the presence of proper medical reimbursement policies are some of the other factors that will make a considerable contribution towards the high share of the actinic keratosis treatment market in the region. Additionally, considerably high awareness of this disease among people is another key cause promoting the growth of the regional market. 

Global Actinic Keratosis Treatment Market Growth, by Region 2020-2026

Asia-Pacific to exhibit considerable growth during the forecast period 2020-2026

The rising patient pool suffering from actinic keratosis, improving healthcare infrastructure, growing R&D funding for new therapies, increasing per capita healthcare expenditure is anticipated to be the key factors driving the growth of the actinic keratosis treatment market in the Asia-Pacific region. Furthermore, the growing geriatric population in the major economies of the region such as China, India, Japan, and South Korea which is highly susceptible to actinic keratosis is another key factor driving the regional growth of the actinic keratosis treatment market. However, low awareness related to the treatment options among the people of the low-income economies of the region is anticipated to hinder the growth of the actinic keratosis treatment market in the Asia-Pacific region.  

Market Players Outlook

The key players in the actinic keratosis treatment market include Bausch Health Companies, Inc., Biofrontera AG, BioLineRx, Ltd., Cipher Pharmaceuticals, Inc., Galderma SA, Hill Dermaceuticals, Inc., LEO Pharma A/S, Valeant Pharmaceuticals Inc., and so on. These players are actively adopting different growth strategies such as new product launches, partnerships, collaboration, and mergers and acquisitions among others to remain competitive in the marketplace. For instance, in March 2020, Almirall, S.A. announced today that the US FDA has completed its filing review and determined that the New Drug Application (NDA) for tirbanibulin, also known as ALM147891, for the treatment of actinic keratosis is sufficiently complete to permit a substantive review. The FDA’s acceptance for filing of the NDA of tirbanibulin, following the acceptance for filing by the EMA, demonstrates a significant step towards its approval both in the US and Europe. 

The Report Covers

• Market value data analysis of 2019 and forecast to 2026.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global actinic keratosis treatment market. Based on the availability of data, information related to the products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.